Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
ALD-52
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Pregabalin
Bufotenin
2C-T-7
6-APDB
Tree.jpgJapanese Garden by Anonymous
LSA
4-HO-MiPT
DOB
4-AcO-MET
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
1P-LSD
DPT
MDMA
PARGY-LAD
2C-B
Experience:25mg 3-MeO-PCP - Enhanced film experience
25C-NBOMe
MET
Oxiracetam
Chameleon.jpgChameleon by Anonymous.
Phenethylamine (compound)
Allylescaline
Experience:250mg DXM - DXM Itch and Trip Report
Pramiracetam
Experience:300µg LSD - Togetherness and the Silent Dusk
5-MeO-MiPT
5-MeO-DiPT
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
2C-C
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
2C-E
4-HO-DiPT
ETH-LAD
Experience:800 seeds LSA - My First Trip Ever
MiPLA
Experience:3-MeO-PCP - Extreme psychosis
25N-NBOMe
MDAI
4-AcO-DET
PRO-LAD
DOI
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Paradise island by Xanny.jpgParadise island by Subsentience
3-MeO-PCE
Coluracetam
2C-I
GABAergic hallucinogens
Bromo-DragonFLY
Escaline
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Selective serotonin reuptake inhibitor
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
6-APB
TMA-2
5F-PB-22
2C-T-21
3-MMC
TMA-6
Ibogaine
JWH-018
25B-NBOMe
Enhancement of colour rose.jpgRose by Chelsea Morgan
Proscaline
Psilocybin mushrooms
Memantine
LSM-775
25C-NBOH
25D-NBOMe
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
JWH-073
5-MeO-DiBF
Cannabis
Piracetam
EPT
Omberacetam
DOM
4-AcO-DMT
2C-T-2
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
4-HO-MPT
4-HO-DPT
Ayahuasca
5-MeO-DALT
Βk-2C-B
Experience:2 tabs DOB - My DOB Nightmare
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
4-HO-MET
Phenylpiracetam
25B-NBOH
Mescaline
Experience:120mg - Garden of The Gods
Efavirenz
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience:3g mimosa / 3g syrian rue - Connecting with my body
4-AcO-MiPT
Experience:1000 Morning Glory seeds - Rediscovering the Self
2C-P
Psilocin
MiPT
1B-LSD
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
25I-NBOMe
3C-E
2C-B-FLY
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
AL-LAD
Experience:4-HO-MiPT / A care free psychedelic getaway
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
DMT
DOC
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Aniracetam
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
LSZ
THJ-2201
25I-NBOH
4-HO-DET
Experience:40mg - Brothermind and the Forest's Hand
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience:BK-2C-B - Various experiences
MPT
DET
Experience:300µg AL-LAD - Don't worry, because you're everyone!
2C-H
2C-D
Methallylescaline
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
1P-ETH-LAD
MDEA
Experience:4x 200ug tabs - You do not need to understand
THJ-018
LSD
Experience:4.5g - The Grand Introduction to Beauty and Fear
DiPT
ΑMT
MDA
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
4-AcO-DiPT
Experience:337mg DMT fumarate - A Day With DMT
5-Hydroxytryptophan
4-FA
Experience:1mg 25c-NBOMe - Experiment in my room
Amanita muscaria
4-HO-EPT

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.